Malcolm Bateman
Direttore Finanziario/CFO presso The Roslin Institute
Profilo
Malcolm Bateman is currently the Chairman at Well Cow Ltd.
and the Finance Director at The Roslin Institute.
He previously worked as the Director at The Genesis Faraday Partnership and Roslin Cell Therapies Ltd.
Additionally, he served as the Director at Censo Biotechnologies Ltd.
from 2008 to 2021.
Posizioni attive di Malcolm Bateman
Società | Posizione | Inizio |
---|---|---|
The Roslin Institute
The Roslin Institute Miscellaneous Commercial ServicesCommercial Services The Roslin Institute conducts genetic research on animal and human health. It focuses on health and welfare of animals, and applications of basic animal sciences in human and veterinary medicine, the livestock industry and food security. The company was founded on April 1, 1993 and is headquartered in Midlothian, the United Kingdom. | Direttore Finanziario/CFO | - |
Well Cow Ltd.
Well Cow Ltd. Agricultural Commodities/MillingProcess Industries Well Cow Ltd. develops technologies relating to animal health monitoring. It offers smart farm concept for remote animal health measurement. The company was incorporated by Toby Mottram on April 13, 2003 and is headquartered in Roslin, the United Kingdom. | Presidente | - |
Precedenti posizioni note di Malcolm Bateman
Società | Posizione | Fine |
---|---|---|
Censo Biotechnologies Ltd.
Censo Biotechnologies Ltd. Miscellaneous Commercial ServicesCommercial Services Censo Biotechnologies Ltd. operates as stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking. It offers human bio-sample procurement, IPSC generation & genome editing, IPSC differentiation, assay development and screening services. The company is headquartered in Midlothian, the United Kingdom. | Direttore/Membro del Consiglio | 16/03/2021 |
Roslin Cell Therapies Ltd.
Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Roslin Cell Therapies Ltd. is a leading contract development and manufacturing services organization focused on advanced cell and gene therapies. The company was established in 2006 and is based in Edinburgh, UK. and has subsidiaries in the United States. Roslin Cell Therapies has a remarkable heritage in the field, having been among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR edited stem cell-based therapy for a major disease to marketing authorization. The British company provides innovative process and analytical development, CGMP clinical and commercial manufacturing for a range of cell types, and CGMP iPSC cell line development, gene editing, and differentiation. With tailored CDMO solutions, Roslin Cell Therapies enables partners to efficiently progress from development to commercialization and deliver life-saving cell and gene therapies worldwide. Peter Alistair Coleman has been the CEO of the company since 2022. | Direttore/Membro del Consiglio | - |
The Genesis Faraday Partnership
The Genesis Faraday Partnership BiotechnologyHealth Technology The Genesis Faraday Partnership researched on genetic and genomic technologies. The company was founded in 2003 and was headquartered in Roslin, the United Kingdom. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
The Roslin Institute
The Roslin Institute Miscellaneous Commercial ServicesCommercial Services The Roslin Institute conducts genetic research on animal and human health. It focuses on health and welfare of animals, and applications of basic animal sciences in human and veterinary medicine, the livestock industry and food security. The company was founded on April 1, 1993 and is headquartered in Midlothian, the United Kingdom. | Commercial Services |
The Genesis Faraday Partnership
The Genesis Faraday Partnership BiotechnologyHealth Technology The Genesis Faraday Partnership researched on genetic and genomic technologies. The company was founded in 2003 and was headquartered in Roslin, the United Kingdom. | Health Technology |
Well Cow Ltd.
Well Cow Ltd. Agricultural Commodities/MillingProcess Industries Well Cow Ltd. develops technologies relating to animal health monitoring. It offers smart farm concept for remote animal health measurement. The company was incorporated by Toby Mottram on April 13, 2003 and is headquartered in Roslin, the United Kingdom. | Process Industries |
Censo Biotechnologies Ltd.
Censo Biotechnologies Ltd. Miscellaneous Commercial ServicesCommercial Services Censo Biotechnologies Ltd. operates as stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking. It offers human bio-sample procurement, IPSC generation & genome editing, IPSC differentiation, assay development and screening services. The company is headquartered in Midlothian, the United Kingdom. | Commercial Services |
Roslin Cell Therapies Ltd.
Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Roslin Cell Therapies Ltd. is a leading contract development and manufacturing services organization focused on advanced cell and gene therapies. The company was established in 2006 and is based in Edinburgh, UK. and has subsidiaries in the United States. Roslin Cell Therapies has a remarkable heritage in the field, having been among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR edited stem cell-based therapy for a major disease to marketing authorization. The British company provides innovative process and analytical development, CGMP clinical and commercial manufacturing for a range of cell types, and CGMP iPSC cell line development, gene editing, and differentiation. With tailored CDMO solutions, Roslin Cell Therapies enables partners to efficiently progress from development to commercialization and deliver life-saving cell and gene therapies worldwide. Peter Alistair Coleman has been the CEO of the company since 2022. | Health Technology |
- Borsa valori
- Insiders
- Malcolm Bateman